eGenesis, a biotechnology company developing human-compatible organs and cells for the treatment of organ failure, is developing several programs across solid organ and cell therapy to address the urgent needs of patients with organ failure and other debilitating diseases. Co-founded by George Church and his former postdoctoral fellow Luhan Yang, eGenesis is committed to ending the global transplant shortage and transforming the treatment of organ failure with lead programs in kidney and islet cell transplantation . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge